1413 / 1835
PI: Craig Moskowitz, MD
Co-PI: JoachimYahalom, MD
SantoshVardhana MD, PhD
Gunjan Shah MD, MS
August 17, 2016
A Phase II Study of Pembrolizumab and
Involved Site Radiation Therapy (ISRT) for
Early Stage Relapsed or Primary Refractory
Hodgkin Lymphoma